1. Home
  2. CVLT vs GKOS Comparison

CVLT vs GKOS Comparison

Compare CVLT & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commvault Systems Inc.

CVLT

Commvault Systems Inc.

HOLD

Current Price

$119.76

Market Cap

6.1B

Sector

Technology

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$108.34

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVLT
GKOS
Founded
1996
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.4B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
CVLT
GKOS
Price
$119.76
$108.34
Analyst Decision
Buy
Strong Buy
Analyst Count
12
13
Target Price
$194.18
$122.08
AVG Volume (30 Days)
659.8K
1.1M
Earning Date
10-28-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.76
N/A
Revenue
$1,095,835,000.00
$469,820,000.00
Revenue This Year
$19.22
$31.15
Revenue Next Year
$12.47
$24.15
P/E Ratio
$68.76
N/A
Revenue Growth
22.02
30.38
52 Week Low
$114.47
$73.16
52 Week High
$200.69
$163.71

Technical Indicators

Market Signals
Indicator
CVLT
GKOS
Relative Strength Index (RSI) 33.25 73.74
Support Level $120.63 $104.11
Resistance Level $125.54 $107.18
Average True Range (ATR) 4.13 4.15
MACD 1.73 0.94
Stochastic Oscillator 46.06 86.00

Price Performance

Historical Comparison
CVLT
GKOS

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: